E-mail a Wiley Online Library Link

Eric T. Wong, Roy Tishler, Loretta Barron and Julian K. Wu Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas Cancer 101

Article first published online: 25 MAY 2004 | DOI: 10.1002/cncr.20339

The authors report their experience with an immunochemotherapy regimen, consisting of rituximab and temozolomide, that exhibited efficacy against recurrent PCNSL and against systemic non-Hodgkin lymphoma that had metastasized to the CNS. This immunochemotherapy combination may offer superior efficacy compared with either agent alone.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

Choose captcha format: Image or Audio. Click here if you need help.